From Reuters.

As war rages and Donald Trump looms, a recent election featured little mention of the ailing $164 billion drugmaker, once so successful it distorted economic figures. In this week’s Viewsroom, Breakingviews columnists discuss the future of weight loss pills, and Novo Nordisk’s place in it.

#novonordisk #business #breakingviews #viewsroom #News #Reuters #Newsfeed

👉 Subscribe: https://reut.rs/4b8fRGn

Keep up with the latest news from around the world: https://www.reuters.com/
Follow Reuters on Facebook: https://www.facebook.com/Reuters
Follow Reuters on X: https://twitter.com/Reuters
Follow Reuters on Instagram: https://www.instagram.com/reuters/?hl=en